CoChat

Astrocyte-Specific Inhibition of the Primary Cilium Suppresses C3 Expression in Reactive Astrocyte

Open access

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; 43 of the 49 sources its claims cite were checked for support.

Abstract

C3-positive reactive astrocytes play a neurotoxic role in various neurodegenerative diseases. However, the mechanisms controlling C3-positive reactive astrocyte induction are largely unknown. We found that the length of the primary cilium, a cellular organelle that receives extracellular signals was increased in C3-positive reactive astrocytes, and the loss or shortening of primary cilium decreased the count of C3-positive reactive astrocytes. Pharmacological experiments suggested that Ca 2+ signalling may synergistically promote C3 expression in reactive astrocytes. Conditional knockout (cKO) mice that specifically inhibit primary cilium formation in astrocytes upon drug stimulation exhibited a reduction in the proportions of C3-positive reactive astrocytes and apoptotic cells in the brain even after the injection of lipopolysaccharide (LPS). Additionally, the novel object recognition (NOR) score observed in the cKO mice was higher than that observed in the neuroinflammation model mice. These results suggest that the primary cilium in astrocytes positively regulates C3 expression. We propose that regulating astrocyte-specific primary cilium signalling may be a novel strategy for the suppression of neuroinflammation. Graphical Abstract The primary cilium of astrocytes are required for the C3 expression in reactive astrocytes. Furthermore, the potentiation of calcium signalling appears to be involved in the promotion of C3 expression in reactive astrocytes.

Overview

CoChat Summary

TL;DR

Astrocyte primary cilia elongate in C3-positive reactive astrocytes, and astrocyte-specific loss of the cilium reduces C3 expression and apoptotic cells after LPS while tending to improve novel object recognition. The paper proposes primary cilium/TRPV4–Ca²⁺ signalling as a target for suppressing neuroinflammation.

Key findings

  • LPS increased astrocytic primary cilium length in mixed glial cultures without changing ciliation rate; cytokine stimulation of enriched astrocytes increased C3-positive cells (PBS 46/779 vs Cyt 293/783, *P* < 0.05) and cilium length (PBS 177 cilia vs Cyt 175 cilia, P* < 0.0001), with an R² of 0.2471 between C3 expression and cilium length.
  • TRPV4 agonist GSK1016790A promoted C3 expression and cilium elongation; the Gq inhibitor YM-254890 prevented C3 increases by cytokines, GSK1016790A, and UTP, and BAPTA-AM reduced C3 induction by cytokines and GSK1016790A.
  • In LPS-treated inflammation model mice, C3-positive astrocytes increased and astrocytic primary cilia were significantly longer than in PBS controls; in astrocyte-specific IFT88 cKO mice, LPS did not significantly increase C3-positive astrocytes (Ctrl+LPS 129/279 vs cKO+LPS 33/210, *P* < 0.05) or TUNEL-positive cells.
  • cKO mice showed a tendency toward attenuated LPS-induced decline in novel object preference, while no significant differences were seen in open field or Y-maze tests.

Methods

  • Mice: C57BL/6J, IFT88^flox/flox; GLAST-CrePR conditional knockout, RU486 induction, and i.p. LPS (1 mg/kg); primary glial/astrocyte cultures from P7 mouse cortices stimulated with LPS or IL-1α/TNF-α/C1q.
  • Interventions: IFT88 siRNA knockdown, TRPV4 agonist/antagonist, UTP, YM-254890, and BAPTA-AM; immunofluorescence for ARL13B, GFAP, C3, and TUNEL; cilium length and ciliation quantified.
  • Behaviour: novel object recognition, open field, and Y-maze; statistics used GraphPad Prism 9 with Kruskal–Wallis/Dunn’s or Mann–Whitney U tests, after Shapiro–Wilk testing.

Limitations

  • The paper states that the physiological relevance of primary cilium elongation in C3-positive reactive astrocytes remains unclear and that the precise relationship between cilium elongation and TRPV4 activation is not clear; further research is required.
  • Evident from the text: several central effects are described as tendencies or nonsignificant, including IFT88 knockdown reducing ciliation/C3, cKO astrocytic ciliation reduction, and cKO attenuation of NOR decline.
  • Evident from the text: IFT88 signal was extremely low even in wild-type brain, so ciliation was assessed with ARL13B; sample sizes were small (typically n = 4–7 biological replicates per group).

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s10571-024-01482-5

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 C3-positive reactive astrocyte induction increases primary cilium length. A Schematic illustration of C3-positive reactive astrocyte induction. Microglial activation by LPS stimulation upregulates the expression of IL-1α, C1q, and TNF-α, increasing the expression of C3 in reactive astrocytes (Liddelow et al. 2017). Figures were created with BioRender.com. B Representative immunostaining image of Arl13B (primary cilium, green) in GFAP-positive cells (astrocytes) (red). Mixed cortical glial cells were treated with 100 ng/ml LPS for 24, 48, and 72 h. The primary cilium indicated by arrow was magnified and shown on the left bottom. Nuclei were stained with Hoechst 33342 (blue). Scale bar; 20 μm. Four independent experiments were performed. C Percentage of astrocytes (GFAP+ARL13B+ cells/GFAP+ cells) with a primary cilium shown Fig. 1B shows in the graph. Glial cells were stimulated with PBS or 100 ng/ml LPS for 24, 48, 72 h. Four independent experiments were performed (PBS 24 h; 107 ciliated cells/259 GFAP+ cells, LPS 24 h; 102 ciliated cells/253 GFAP+ cells, PBS 48 h; 136 ciliated cells/290 GFAP+ cells, LPS 48 h; 121 ciliated cells/270 GFAP+ cells, PBS 72 h; 145 ciliated cells/347 GFAP+ cells, LPS 72 h; 96 ciliated cells/236 GFAP+ cells). The Mann‒Whitney U test was performed. ns, nonsignificant. Error bar indicates SD. D The astrocytic primary cilium length shown in Fig. 1B was measured (PBS 24 h; 108 cilia, LPS 24 h; 92 cilia, PBS 48 h; 107 cilia, LPS 48 h; 97 cilia, PBS 72 h; 93 cilia, LPS 72 h; 84 cilia). Four independent experiments were performed. Error bar indicates SD. ***P < 0.001, ****P < 0.0001. (Mann‒Whitney U test). E Representative image of Arl13B (red) and C3 (green) and nuclei (Hoechst 33342, blue) in enriched astrocytes. Astrocytes were enriched from glial mixture culture and stimulated with PBS or a cytokine mixture (3 ng/mL IL-1α, 30 ng/ml TNFα, 400 ng/ml C1q) for 24 h. The arrow indicates the primary cilium. Scale bar; 5 μm. Four independent experiments were performed. F (left) Percentage of C3-positive cells (C3+ cells/total cells) in enriched astrocytes culture shown in Fig. 1E. Four independent experiments were performed. (PBS; 46 C3+ cells /779 total cells, Cyt; 293 C3+ cells /783 total cells) Error bar indicates SD. *P < 0.05, (Mann‒Whitney U test). (Right) Astrocytic cilia length is shown in the graph (PBS; 177 cilia, Cyt; 175 cilia). Four independent experiments were performed. Error bar indicates SD. ****P < 0.0001. (Mann‒Whitney U test). G The correlation coefficient between the expression level of C3 and the length of cilium. Primary cilium length and C3 expression intensity was measured by Image J. Images of astrocytes stimulated with PBS or cytokines were randomly selected, and five images were chosen for each condition. Quantification was performed for all cells within the selected images
Fig. 1 C3-positive reactive astrocyte induction increases primary cilium length. A Schematic illustration of C3-positive reactive astrocyte induction. Microglial activation by LPS stimulation upregulates the expression of IL-1α, C1q, and TNF-α, increasing the expression of C3 in reactive astrocytes (Liddelow et al. 2017). Figures were created with BioRender.com. B Representative immunostaining image of Arl13B (primary cilium, green) in GFAP-positive cells (astrocytes) (red). Mixed cortical glial cells were treated with 100 ng/ml LPS for 24, 48, and 72 h. The primary cilium indicated by arrow was magnified and shown on the left bottom. Nuclei were stained with Hoechst 33342 (blue). Scale bar; 20 μm. Four independent experiments were performed. C Percentage of astrocytes (GFAP+ARL13B+ cells/GFAP+ cells) with a primary cilium shown Fig. 1B shows in the graph. Glial cells were stimulated with PBS or 100 ng/ml LPS for 24, 48, 72 h. Four independent experiments were performed (PBS 24 h; 107 ciliated cells/259 GFAP+ cells, LPS 24 h; 102 ciliated cells/253 GFAP+ cells, PBS 48 h; 136 ciliated cells/290 GFAP+ cells, LPS 48 h; 121 ciliated cells/270 GFAP+ cells, PBS 72 h; 145 ciliated cells/347 GFAP+ cells, LPS 72 h; 96 ciliated cells/236 GFAP+ cells). The Mann‒Whitney U test was performed. ns, nonsignificant. Error bar indicates SD. D The astrocytic primary cilium length shown in Fig. 1B was measured (PBS 24 h; 108 cilia, LPS 24 h; 92 cilia, PBS 48 h; 107 cilia, LPS 48 h; 97 cilia, PBS 72 h; 93 cilia, LPS 72 h; 84 cilia). Four independent experiments were performed. Error bar indicates SD. ***P < 0.001, ****P < 0.0001. (Mann‒Whitney U test). E Representative image of Arl13B (red) and C3 (green) and nuclei (Hoechst 33342, blue) in enriched astrocytes. Astrocytes were enriched from glial mixture culture and stimulated with PBS or a cytokine mixture (3 ng/mL IL-1α, 30 ng/ml TNFα, 400 ng/ml C1q) for 24 h. The arrow indicates the primary cilium. Scale bar; 5 μm. Four independent experiments were performed. F (left) Percentage of C3-positive cells (C3+ cells/total cells) in enriched astrocytes culture shown in Fig. 1E. Four independent experiments were performed. (PBS; 46 C3+ cells /779 total cells, Cyt; 293 C3+ cells /783 total cells) Error bar indicates SD. *P < 0.05, (Mann‒Whitney U test). (Right) Astrocytic cilia length is shown in the graph (PBS; 177 cilia, Cyt; 175 cilia). Four independent experiments were performed. Error bar indicates SD. ****P < 0.0001. (Mann‒Whitney U test). G The correlation coefficient between the expression level of C3 and the length of cilium. Primary cilium length and C3 expression intensity was measured by Image J. Images of astrocytes stimulated with PBS or cytokines were randomly selected, and five images were chosen for each condition. Quantification was performed for all cells within the selected imagesCC BY · PubMed Central
Fig. 2 TRPV4 activation induces C3-positive reactive astrocyte. A Representative image of C3 (green), GFAP (red), and Hoechst 33342 (blue) in enriched astrocytes. Cells were stimulated with PBS (negative control), a cytokine mixture (Cyt) (3 ng/mL IL-1α, 30 ng/ml TNFα, 400 ng/ml C1q), 100 nM GSK1016790A (GSK101), 100 nM GSK2193874 (GSK219) for 24 h. Scale bar; 20 µm. n = 5 independent experiments B Representative image of Arl13B (green) and Hoechst 33342 (blue) in enriched astrocytes. Cells were stimulated with a cytokine mixture (Cyt) (3 ng/mL IL-1α, 30 ng/ml TNFα, 400 ng/ml C1q), 100 nM GSK1016790A (GSK101), 100 nM GSK2193874 (GSK219) for 24 h. The primary cilium indicated by arrow was magnified and shown on the right bottom. n = 4 independent experiments. Scale bar; 20 µm. C The percentage of C3-positive astrocytes (C3+GFAP+ cells/GFAP+ cells) shown Fig. 2A shows in the graph (PBS; 76 C3+ GFAP+ cells/484 GFAP+ cells, Cyt; 244 C3+ GFAP+ cells/378 GFAP+ cells, GSK101; 247 C3+ GFAP+ cells/408 GFAP+ cells, GSK219; 55 C3+ GFAP+ cells/373 GFAP+ cells, Cyt + GSK101; 268 C3+ cells/439 total cells, Cyt + GSK219; 99 C3+ cells/321 total cells, GSK101 + GSK219; 94 C3+ GFAP+ cells/ 409 GFAP+ cells, Cyt + GSK101 + GSK219; 164 C3+ GFAP+ cells/399 GFAP+ cells). *P < 0.05, **P < 0.01, ns, nonsignificant. (Kruskal–Wallis test, Dunn’s multiple comparison). n = 5 independent experiments. Error bar indicates SD. D Cilium length shown in Fig. 2B shows in graph (ctrl; 176 cilia, Cyt; 141 cilia, GSK101; 151 cilia, GSK219; 210 cilia). **P < 0.01, ****P < 0.0001, ns, nonsignificant (Kruskal–Wallis test, Dunn’s multiple comparison). Error bar indicates SD. n = 4 independent experiments. E The percentage of ciliated astrocytes (Arl13B+ GFAP+ cells/GFAP+ cells) shown Fig. 2B shows in the graph (ctrl; 190 ciliated cells/308 GFAP+ cells, Cyt; 159 ciliated cells/200 GFAP+ cells, GSK101; 169 ciliated cells/198 GFAP+ cells, GSK219; 228 ciliated cells/278 GFAP+ cells). ns, nonsignificant (Kruskal–Wallis test, Dunn’s multiple comparison). n = 4 independent experiments. Error bar indicates SD. F Representative image of C3 (green), GFAP (red), and Hoechst 33342 (blue) in purified primary astrocytes. Cells were stimulated with PBS (negative control), a cytokine mixture (Cyt) (3 ng/mL IL-1α, 30 ng/ml TNFα, 400 ng/ml C1q), 100 nM GSK1016790A (GSK101), 100 nM UTP, 100 nM YM-254890 (YM-254) for 24 h. n = 5 independent experiments. Scale bar; 20 µm. G The percentage of C3-positive astrocytes (C3+ GFAP+ cells/GFAP+ cells) shown Fig. 2F shows in the graph (PBS; 23 C3+ GFAP+ cells/278 GFAP+ cells, Cyt; 138 C3+ GFAP+ cells/294 GFAP+ cells, GSK101; 117 C3+ GFAP+ cells/ 312 GFAP+ cells, UTP; 152 C3+ GFAP+ cells/305 GFAP+ cells, YM-254; 23 C3+ GFAP+ cells/278 GFAP+ cells, Cyt + YM-254; 54 C3+ GFAP+ cells/321 GFAP+ cells, GSK101 + YM-254; 41 C3+ GFAP+ cells/329 GFAP+ cells, UTP + YM-254; 32 C3+ GFAP+ cells/270 GFAP+ cells). **P < 0.01, ***P < 0.001, ****P < 0.0001, ns, nonsignificant. (Kruskal–Wallis test, Dunn’s multiple comparison). Error bar indicates SD. n = 5 independent experiments. H Representative image of C3 (green), GFAP (red), and Hoechst 33342 (blue) in enriched astrocytes. Cells were stimulated with a cytokine mixture (Cyt) (3 ng/mL IL-1α, 30 ng/ml TNFα, 400 ng/ml C1q), 100 nM GSK1016790A (GSK101) and 1 µM BAPTA-AM for 24 h. n = 5 independent experiments. Scale bar; 20 µm. I The percentage of C3-positive astrocytes (C3+ GFAP+ cells/GFAP+ cells) shown Fig. 2H shows in the graph (PBS, BAPTA-; 17 C3+ GFAP+ cells/354 GFAP+ cells, PBS, BAPTA + ; 18 C3+ GFAP+ cells/318 GFAP+ cells, Cyt, BAPTA-; 128 C3+ GFAP+ cells/ 275 GFAP+ cells, Cyt, BAPTA + ; 27 C3+ GFAP+ cells/192 GFAP+ cells, GSK101, BAPTA-; 127 C3+ cells/270 total cells, GSK101, BAPTA + ; 49 C3+ cells/313 total cells). *P < 0.05, **P < 0.01, ns, nonsignificant (The Mann‒Whitney U test). n = 5 independent experiments
Fig. 2 TRPV4 activation induces C3-positive reactive astrocyte. A Representative image of C3 (green), GFAP (red), and Hoechst 33342 (blue) in enriched astrocytes. Cells were stimulated with PBS (negative control), a cytokine mixture (Cyt) (3 ng/mL IL-1α, 30 ng/ml TNFα, 400 ng/ml C1q), 100 nM GSK1016790A (GSK101), 100 nM GSK2193874 (GSK219) for 24 h. Scale bar; 20 µm. n = 5 independent experiments B Representative image of Arl13B (green) and Hoechst 33342 (blue) in enriched astrocytes. Cells were stimulated with a cytokine mixture (Cyt) (3 ng/mL IL-1α, 30 ng/ml TNFα, 400 ng/ml C1q), 100 nM GSK1016790A (GSK101), 100 nM GSK2193874 (GSK219) for 24 h. The primary cilium indicated by arrow was magnified and shown on the right bottom. n = 4 independent experiments. Scale bar; 20 µm. C The percentage of C3-positive astrocytes (C3+GFAP+ cells/GFAP+ cells) shown Fig. 2A shows in the graph (PBS; 76 C3+ GFAP+ cells/484 GFAP+ cells, Cyt; 244 C3+ GFAP+ cells/378 GFAP+ cells, GSK101; 247 C3+ GFAP+ cells/408 GFAP+ cells, GSK219; 55 C3+ GFAP+ cells/373 GFAP+ cells, Cyt + GSK101; 268 C3+ cells/439 total cells, Cyt + GSK219; 99 C3+ cells/321 total cells, GSK101 + GSK219; 94 C3+ GFAP+ cells/ 409 GFAP+ cells, Cyt + GSK101 + GSK219; 164 C3+ GFAP+ cells/399 GFAP+ cells). *P < 0.05, **P < 0.01, ns, nonsignificant. (Kruskal–Wallis test, Dunn’s multiple comparison). n = 5 independent experiments. Error bar indicates SD. D Cilium length shown in Fig. 2B shows in graph (ctrl; 176 cilia, Cyt; 141 cilia, GSK101; 151 cilia, GSK219; 210 cilia). **P < 0.01, ****P < 0.0001, ns, nonsignificant (Kruskal–Wallis test, Dunn’s multiple comparison). Error bar indicates SD. n = 4 independent experiments. E The percentage of ciliated astrocytes (Arl13B+ GFAP+ cells/GFAP+ cells) shown Fig. 2B shows in the graph (ctrl; 190 ciliated cells/308 GFAP+ cells, Cyt; 159 ciliated cells/200 GFAP+ cells, GSK101; 169 ciliated cells/198 GFAP+ cells, GSK219; 228 ciliated cells/278 GFAP+ cells). ns, nonsignificant (Kruskal–Wallis test, Dunn’s multiple comparison). n = 4 independent experiments. Error bar indicates SD. F Representative image of C3 (green), GFAP (red), and Hoechst 33342 (blue) in purified primary astrocytes. Cells were stimulated with PBS (negative control), a cytokine mixture (Cyt) (3 ng/mL IL-1α, 30 ng/ml TNFα, 400 ng/ml C1q), 100 nM GSK1016790A (GSK101), 100 nM UTP, 100 nM YM-254890 (YM-254) for 24 h. n = 5 independent experiments. Scale bar; 20 µm. G The percentage of C3-positive astrocytes (C3+ GFAP+ cells/GFAP+ cells) shown Fig. 2F shows in the graph (PBS; 23 C3+ GFAP+ cells/278 GFAP+ cells, Cyt; 138 C3+ GFAP+ cells/294 GFAP+ cells, GSK101; 117 C3+ GFAP+ cells/ 312 GFAP+ cells, UTP; 152 C3+ GFAP+ cells/305 GFAP+ cells, YM-254; 23 C3+ GFAP+ cells/278 GFAP+ cells, Cyt + YM-254; 54 C3+ GFAP+ cells/321 GFAP+ cells, GSK101 + YM-254; 41 C3+ GFAP+ cells/329 GFAP+ cells, UTP + YM-254; 32 C3+ GFAP+ cells/270 GFAP+ cells). **P < 0.01, ***P < 0.001, ****P < 0.0001, ns, nonsignificant. (Kruskal–Wallis test, Dunn’s multiple comparison). Error bar indicates SD. n = 5 independent experiments. H Representative image of C3 (green), GFAP (red), and Hoechst 33342 (blue) in enriched astrocytes. Cells were stimulated with a cytokine mixture (Cyt) (3 ng/mL IL-1α, 30 ng/ml TNFα, 400 ng/ml C1q), 100 nM GSK1016790A (GSK101) and 1 µM BAPTA-AM for 24 h. n = 5 independent experiments. Scale bar; 20 µm. I The percentage of C3-positive astrocytes (C3+ GFAP+ cells/GFAP+ cells) shown Fig. 2H shows in the graph (PBS, BAPTA-; 17 C3+ GFAP+ cells/354 GFAP+ cells, PBS, BAPTA + ; 18 C3+ GFAP+ cells/318 GFAP+ cells, Cyt, BAPTA-; 128 C3+ GFAP+ cells/ 275 GFAP+ cells, Cyt, BAPTA + ; 27 C3+ GFAP+ cells/192 GFAP+ cells, GSK101, BAPTA-; 127 C3+ cells/270 total cells, GSK101, BAPTA + ; 49 C3+ cells/313 total cells). *P < 0.05, **P < 0.01, ns, nonsignificant (The Mann‒Whitney U test). n = 5 independent experimentsCC BY · PubMed Central
Fig. 3 LPS injection elongates the astrocytic primary cilium in mice brain. A Representative image of GFAP (astrocytes, red), Arl13B (primary cilium, green), and nuclei (blue) in the mouse hippocampal area. Three-month-old mice were i.p. injected with 1 mg/kg LPS twice a week for 6 weeks. Scale bar; 10 μm. PBS-treated mice; n = 5 (biological replicates). LPS-treated mice; n = 5 (biological replicates). B The percentage of ciliated astrocytes (Arl13B+ GFAP+ cells/GFAP+ cells) (left, PBS; 75 ciliated cells /521 GFAP+ cells, LPS; 36 ciliated cells /382 GFAP+ cells), percentage of ciliated GFAP-negative cells (Arl13B+ GFAP− cells/GFAP− cells) (middle, PBS; 31 ciliated cells /341 GFAP− cells, LPS; 20 ciliated cells /209 GFAP− cells), and astrocytic primary cilium length (right, PBS; 103 primary cilia, LPS; 36 primary cilia) shown in Fig. 3A are shown in the graph. ****P < 0.0001, ns, nonsignificant. (Mann‒Whitney U test). Five biological replicates (5 mice) were examined respectively. Error bar indicates SD
Fig. 3 LPS injection elongates the astrocytic primary cilium in mice brain. A Representative image of GFAP (astrocytes, red), Arl13B (primary cilium, green), and nuclei (blue) in the mouse hippocampal area. Three-month-old mice were i.p. injected with 1 mg/kg LPS twice a week for 6 weeks. Scale bar; 10 μm. PBS-treated mice; n = 5 (biological replicates). LPS-treated mice; n = 5 (biological replicates). B The percentage of ciliated astrocytes (Arl13B+ GFAP+ cells/GFAP+ cells) (left, PBS; 75 ciliated cells /521 GFAP+ cells, LPS; 36 ciliated cells /382 GFAP+ cells), percentage of ciliated GFAP-negative cells (Arl13B+ GFAP− cells/GFAP− cells) (middle, PBS; 31 ciliated cells /341 GFAP− cells, LPS; 20 ciliated cells /209 GFAP− cells), and astrocytic primary cilium length (right, PBS; 103 primary cilia, LPS; 36 primary cilia) shown in Fig. 3A are shown in the graph. ****P < 0.0001, ns, nonsignificant. (Mann‒Whitney U test). Five biological replicates (5 mice) were examined respectively. Error bar indicates SDCC BY · PubMed Central
Fig. 4 Astrocyte-specific IFT88 gene knockout reduces C3 expression. A Timeline of experiments. Eight-week-old mice (IFT88flox/flox; GLAST-CrePR−/− (ctrl) or IFT88flox/flox; GLAST-CrePR± (cKO)) were i.p. injected with 20 nmol/head RU486 twice a week for 2 weeks. Three days after the final injection of RU486, the mice were i.p. injected with 1 mg/kg LPS twice a week. A control group was administered with an equal volume of PBS. Two days after the second LPS injection, an NOR test was performed. B Representative image of Arl13B (green), GFAP (red) and nuclei (Hoechst 33342, blue) in the mouse hippocampal area. Scale bar; 5 μm. The arrow indicates the primary cilium. PBS administration to ctrl mice; n = 5 (biological replicates). LPS administration to ctrl mice; n = 6 (biological replicates). PBS administration to cKO mice; n = 7 (biological replicates). LPS administration to cKO mice; n = 6 (biological replicates). C Percentage of ciliated astrocytes (Arl13B+ GFAP+ cells/GFAP+ cells) in the brain (left, Ctrl + PBS; 15 Arl13B+ GFAP+ cells /119 GFAP+ cells, Ctrl + LPS; 26 Arl13B+ GFAP+ cells /243 GFAP+ cells, cKO + PBS; 14 Arl13B+ GFAP+ cells /338 GFAP+ cells, cKO + LPS; 4 Arl13B+ GFAP+ cells /317 GFAP+ cells), percentage of ciliated GFAP-negative cells (Arl13B+GFAP− cells/GFAP− cells) (middle, Ctrl + PBS; 84 Arl13B+ GFAP− cells /843 GFAP− cells, Ctrl + LPS; 54 Arl13B+ GFAP− cells /873 GFAP− cells, cKO + PBS; 206 Arl13B+ GFAP− cells /1730 GFAP− cells, cKO + LPS; 104 Arl13B+ GFAP− cells /840 GFAP− cells) and cilium length in non-astrocytic cells (right, Ctrl + PBS; 55 cilia, Ctrl + LPS; 45 cilia, cKO + PBS; 51 cilia, cKO + LPS; 57 cilia) shown in Fig. 4B. *P < 0.05, ns, nonsignificant. (Kruskal–Wallis test, Dunn’s multiple comparison). Error bar indicates SD. PBS administration to ctrl mice; n = 5 (biological replicates). LPS administration to ctrl mice; n = 6 (biological replicates). PBS administration to cKO mice; n = 7 (biological replicates). LPS administration to cKO mice; n = 6 (biological replicates). D Representative image of C3 (green), GFAP (red) and nuclei (Hoechst 33342, blue) in the mouse hippocampal area. Scale bar; 20 μm. PBS administration to ctrl mice; n = 5 (biological replicates). LPS administration to ctrl mice; n = 6 (biological replicates). PBS administration to cKO mice; n = 7 (biological replicates). LPS administration to cKO mice; n = 6 (biological replicates). E Percentage of C3-positive astrocytes (C3+GFAP+ cells/GFAP+ cells) shown in Fig. 4D. PBS-treated ctrl mice; n = 5 (biological replicates, 32 C3+ GFAP+/135 GFAP+ cells). LPS-treated ctrl mice; n = 6 (biological replicates, 129 C3+ GFAP+ cells/279 GFAP+ cells). PBS-treated cKO mice; n = 7 (biological replicates, 25 C3+ GFAP+ cells /239 GFAP+ cells). LPS-treated cKO mice; n = 6 (biological replicates, 33 C3+ GFAP+ cells /210 GFAP+ cells). *P < 0.05, ns, nonsignificant. (Kruskal–Wallis test, Dunn’s multiple comparison). Error bar indicates SD. F A representative image of early apoptotic cells detected by the TUNEL method in mouse hippocampal CA1/CA3 regions (left). Scale bar; 20 μm. PBS-treated ctrl mice; n = 6 (biological replicates). LPS-treated ctrl mice; n = 6 (biological replicates). PBS-treated cKO mice; n = 6 (biological replicates). LPS-treated cKO mice; n = 6 (biological replicates). Positive control (PC) slides were used as staining controls. The number of TUNEL-positive cells is shown in the graph (right). *P < 0.05, **P < 0.01, ns, nonsignificant. (Kruskal–Wallis test, Dunn’s multiple comparison). Error bar indicates SD
Fig. 4 Astrocyte-specific IFT88 gene knockout reduces C3 expression. A Timeline of experiments. Eight-week-old mice (IFT88flox/flox; GLAST-CrePR−/− (ctrl) or IFT88flox/flox; GLAST-CrePR± (cKO)) were i.p. injected with 20 nmol/head RU486 twice a week for 2 weeks. Three days after the final injection of RU486, the mice were i.p. injected with 1 mg/kg LPS twice a week. A control group was administered with an equal volume of PBS. Two days after the second LPS injection, an NOR test was performed. B Representative image of Arl13B (green), GFAP (red) and nuclei (Hoechst 33342, blue) in the mouse hippocampal area. Scale bar; 5 μm. The arrow indicates the primary cilium. PBS administration to ctrl mice; n = 5 (biological replicates). LPS administration to ctrl mice; n = 6 (biological replicates). PBS administration to cKO mice; n = 7 (biological replicates). LPS administration to cKO mice; n = 6 (biological replicates). C Percentage of ciliated astrocytes (Arl13B+ GFAP+ cells/GFAP+ cells) in the brain (left, Ctrl + PBS; 15 Arl13B+ GFAP+ cells /119 GFAP+ cells, Ctrl + LPS; 26 Arl13B+ GFAP+ cells /243 GFAP+ cells, cKO + PBS; 14 Arl13B+ GFAP+ cells /338 GFAP+ cells, cKO + LPS; 4 Arl13B+ GFAP+ cells /317 GFAP+ cells), percentage of ciliated GFAP-negative cells (Arl13B+GFAP− cells/GFAP− cells) (middle, Ctrl + PBS; 84 Arl13B+ GFAP− cells /843 GFAP− cells, Ctrl + LPS; 54 Arl13B+ GFAP− cells /873 GFAP− cells, cKO + PBS; 206 Arl13B+ GFAP− cells /1730 GFAP− cells, cKO + LPS; 104 Arl13B+ GFAP− cells /840 GFAP− cells) and cilium length in non-astrocytic cells (right, Ctrl + PBS; 55 cilia, Ctrl + LPS; 45 cilia, cKO + PBS; 51 cilia, cKO + LPS; 57 cilia) shown in Fig. 4B. *P < 0.05, ns, nonsignificant. (Kruskal–Wallis test, Dunn’s multiple comparison). Error bar indicates SD. PBS administration to ctrl mice; n = 5 (biological replicates). LPS administration to ctrl mice; n = 6 (biological replicates). PBS administration to cKO mice; n = 7 (biological replicates). LPS administration to cKO mice; n = 6 (biological replicates). D Representative image of C3 (green), GFAP (red) and nuclei (Hoechst 33342, blue) in the mouse hippocampal area. Scale bar; 20 μm. PBS administration to ctrl mice; n = 5 (biological replicates). LPS administration to ctrl mice; n = 6 (biological replicates). PBS administration to cKO mice; n = 7 (biological replicates). LPS administration to cKO mice; n = 6 (biological replicates). E Percentage of C3-positive astrocytes (C3+GFAP+ cells/GFAP+ cells) shown in Fig. 4D. PBS-treated ctrl mice; n = 5 (biological replicates, 32 C3+ GFAP+/135 GFAP+ cells). LPS-treated ctrl mice; n = 6 (biological replicates, 129 C3+ GFAP+ cells/279 GFAP+ cells). PBS-treated cKO mice; n = 7 (biological replicates, 25 C3+ GFAP+ cells /239 GFAP+ cells). LPS-treated cKO mice; n = 6 (biological replicates, 33 C3+ GFAP+ cells /210 GFAP+ cells). *P < 0.05, ns, nonsignificant. (Kruskal–Wallis test, Dunn’s multiple comparison). Error bar indicates SD. F A representative image of early apoptotic cells detected by the TUNEL method in mouse hippocampal CA1/CA3 regions (left). Scale bar; 20 μm. PBS-treated ctrl mice; n = 6 (biological replicates). LPS-treated ctrl mice; n = 6 (biological replicates). PBS-treated cKO mice; n = 6 (biological replicates). LPS-treated cKO mice; n = 6 (biological replicates). Positive control (PC) slides were used as staining controls. The number of TUNEL-positive cells is shown in the graph (right). *P < 0.05, **P < 0.01, ns, nonsignificant. (Kruskal–Wallis test, Dunn’s multiple comparison). Error bar indicates SDCC BY · PubMed Central
Fig. 5 The specific inhibition of primary cilium formation in astrocytes ameliorates LPS-induced cognitive impairment. A Illustration of the mouse behavioural test. The novel object recognition (NOR) test (left), open field (OF) test (middle) and Y-maze test (right) were performed. Figures were created with BioRender.com. B Results of behavioural (NOR; left, OF; middle, Y-maze; right) studies in 3-month-old PBS- and LPS-injected C57BL/6 J mice. PBS-treated mice; n = 6 (biological replicates). LPS-treated mice; n = 6 (biological replicates). **P < 0.01, ns, nonsignificant. (Mann‒Whitney U test). Error bar indicates SD. C Results of ORT studies in cKO mice. PBS-treated ctrl mice; n = 9 (biological replicates). LPS-treated ctrl mice; n=6 (biological replicates). PBS-treated cKO mice; n=6 (biological replicates). LPS-treated cKO mice; n=7 (biological replicates). *P < <0.05, **P < 0.01, ns, nonsignificant. (Kruskal–Wallis test, Dunn’s multiple comparison). Error bar indicates SD
Fig. 5 The specific inhibition of primary cilium formation in astrocytes ameliorates LPS-induced cognitive impairment. A Illustration of the mouse behavioural test. The novel object recognition (NOR) test (left), open field (OF) test (middle) and Y-maze test (right) were performed. Figures were created with BioRender.com. B Results of behavioural (NOR; left, OF; middle, Y-maze; right) studies in 3-month-old PBS- and LPS-injected C57BL/6 J mice. PBS-treated mice; n = 6 (biological replicates). LPS-treated mice; n = 6 (biological replicates). **P < 0.01, ns, nonsignificant. (Mann‒Whitney U test). Error bar indicates SD. C Results of ORT studies in cKO mice. PBS-treated ctrl mice; n = 9 (biological replicates). LPS-treated ctrl mice; n=6 (biological replicates). PBS-treated cKO mice; n=6 (biological replicates). LPS-treated cKO mice; n=7 (biological replicates). *P < <0.05, **P < 0.01, ns, nonsignificant. (Kruskal–Wallis test, Dunn’s multiple comparison). Error bar indicates SDCC BY · PubMed Central

Verification

Claims the paper makes

30 Valid · 0 Not valid · 2 Not checked · 61 Own results and interpretations

55 more claims · 5 with their cited sources checked

Create a free account to see all 93 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 24
  • It may state two separate claims as one. 16

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 55 references

Cited by

See all 9

Metadata

Authors
Muhamad, N. A., Masutani, K., Furukawa, S., Yuri, S., Toriyama, M., Matsumoto, C., Itoh, S., Shinagawa, Y., Isotani, A., Toriyama, M., & Itoh, H.
Affiliations
  • Nara Institute of Science and Technology (JP)
  • Kwansei Gakuin University (JP)
Corresponding author
  • Toriyama, Michinori
  • Toriyama, Manami
  • Itoh, Hiroshi
Venue
Cellular and Molecular Neurobiology
Published
2024-06-01
Volume
44
Issue
1
Pages
48-48
ISSN
  • 0272-4340 (ISSN-L)
  • 1573-6830
OpenAlex
W4399262486
Cited by
9
References
53
Citations by year
2026: 3 · 2025: 6
FWCI
1.43
Type
journal article
Language
en
Open access
Licence
Locations
  • Cellular and Molecular Neurobiology (publishedVersion, cc-by)
  • Research Square (submittedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by)
Funders
Japan Society for the Promotion of Science (JP21K06382, JP21K15087, JP21K06837)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Keywords
primary cilia, reactive astrocytes, complement C3, calcium signaling, neuroinflammation, lipopolysaccharide, astrocyte apoptosis, novel object recognition, conditional knockout mice, neurodegenerative diseases
MeSH terms
Animals, Astrocytes, Cilia, Complement C3, Lipopolysaccharides, Mice, Inbred C57BL, Apoptosis, Mice, Knockout, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-11-02, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-02 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Astrocyte-Specific Inhibition of the Primary Cilium Suppresses C3 Expression in Reactive Astrocyte. https://app.cochat.ai/papers/10.1007/s10571-024-01482-5
The paper
Muhamad, N. A., Masutani, K., Furukawa, S., Yuri, S., Toriyama, M., Matsumoto, C., Itoh, S., Shinagawa, Y., Isotani, A., Toriyama, M., & Itoh, H. (2024). Astrocyte-Specific Inhibition of the Primary Cilium Suppresses C3 Expression in Reactive Astrocyte. Cellular and Molecular Neurobiology. https://doi.org/10.1007/s10571-024-01482-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.